NewsRoom Articles - Page 36 of 207

TuesdayMar 26, 2024 9:45 am

Astiva Health’s Innovative Strategies for Enhancing Senior Mobility and Independence

Astiva Health Inc. is pioneering transformative healthcare for seniors, with a focus on enhancing mobility and promoting independence. This innovative approach places a strong emphasis on seniors as active participants in their healthcare journey, representing a shift towards a more interactive and preventive model of care. Embracing Active Participation Central to Astiva Health's mission is empowering seniors to engage actively in their healthcare decisions, supporting their flourishing in later years. The CDC highlights physical activity's crucial role in preventing chronic diseases among seniors, noting that regular physical activity can significantly reduce health risks associated with inactivity (CDC, 2020). Tailored Exercise…

TuesdayMar 26, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Announces Operational Highlights for Lead Therapeutic Candidate for ALS and MS

Clene’s recently released 2023 financial and operational updates highlight the company’s developments for the treatment of amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis CNM-Au8(R) functions as a neuroprotective and remyelinating therapy in neurodegenerative diseases Recent data from the randomized, double-blind, placebo-controlled HEALEY-ALS Platform Trial and its open-label extension, reported by Clene in December 2023, revealed encouraging outcomes on survival and delayed clinical worsening Clene recently provided perspectives on its achievements and the development path for CNM-Au8(R) during its participation in the 36th Annual ROTH Conference, which was held March 18-19, 2024 Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene…

MondayMar 25, 2024 10:00 am

New Study Leverages Real-World Data to Assess Differences in Parkinson’s Progression

Recent research assessed the differences in Parkinson’s disease progression between research populations and real-world data. Parkinson’s disease is a progressive disorder that affects the nervous system and body parts controlled by the nerves. Illness-modifying treatments haven’t been successful for Parkinson’s, with some therapies that have shown promise in trials failing at later stages. The primary challenge to developing illness-modifying treatments for this particular condition is the fact that molecular processes that drive pathogenesis haven’t been understood properly. Additionally, diverse ages on the condition’s onset and different progression patterns indicate heterogeneity. For their research, the scientists used Harvard Biomarkers studies and…

FridayMar 22, 2024 10:00 am

Gene Signature Could Predict NSC Lung Cancer Response to Immunotherapy

New research has found genes that could help forecast how non-small cell lung cancer may respond to a treatment combination of low-dose radiation and immunotherapy. The researchers explained that these genes could help identify tumors that were more likely to be destroyed by immunotherapies. Immunotherapies work by activating an individual’s immune system to fight the cancer. Despite saving numerous lives, however, only about 25% of patients respond to it. Being able to predict who could benefit from this new discovery and the underlying mechanism of action would greatly benefit patients who gain no benefit from other modes of treatment. For…

ThursdayMar 21, 2024 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) Developing Pipeline to Address Unmet Needs in Autism Spectrum Disorder via Suramin Sodium

Autism (“ASD”) is a global problem, with no generally accepted treatment. In the UK alone, between 1998 and 2018, research has found a greater than 780% increase in the number of autism cases PaxMedica is focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of ASD and other serious conditions with intractable neurologic symptoms The ASD therapeutics market was valued at $2.01 billion in 2023 and is expected to reach $3.42 billion by 2030, growing at a CAGR of 7.9% There is currently no approved pharmacologic treatment targeting the cause and symptoms. Current treatments only address the…

WednesdayMar 20, 2024 11:00 am

How AI Can Help in Crafting Memorable eCommerce Experiences

The emergence of incredibly advanced artificial intelligence (AI)-powered tools in recent years has provided e-commerce businesses with an effective tool for creating memorable customer experiences. A growing number of consumers are buying goods online, thanks to the convenience, variety, better prices and safety offered by online marketplaces. Evolving consumer behavior in the wake of coronavirus-related lockdowns has also contributed to the increase in online shopping. With more businesses worldwide opening online stores, competition in the e-commerce space is heating up fast. Consequently, providing customers with a memorable and enjoyable shopping experience will be key for online retailers who want to…

MondayMar 18, 2024 10:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors

CNS Pharmaceuticals recently appointed Amy Mahery, a biotech commercialization leader, to its Board of Directors Ms. Mahery brings over 20 years’ experience, having worked with small and large companies, and has held diverse commercial leadership roles in the U.S. and globally The company believes Ms. Mahery’s guidance, insight, and vast pharma industry network will indeed be invaluable as the company advances Berubicin, its flagship drug candidate, toward completion of its global potentially pivotal clinical trial and potential regulatory approval The company recently completed the enrollment of patients in its potentially pivotal global clinical trial Ms. Mahery believes Berubicin represents an…

MondayMar 18, 2024 10:30 am

New Research Sheds Light on the Initial Stages of Brain Cancer Development

Recent research has identified processes that could lead to the growth of tumors. The research was conducted by a team at the University of Plymouth’s Brain Tumour Research Centre, led by Dr. Claudia Barros. This institution is focused on providing new understanding of certain groups of common, low-grade brain tumors. For their research, the investigators used Drosophila fruit flies. This allowed them to identify changes that could play a role in a healthy cell becoming a cancerous one in the brain. Once this was done, investigators translated their discovery using glioma cells. Glioma is a tumor commonly found in the…

FridayMar 15, 2024 11:00 am

New AI Model Can Detect Diseases by Analyzing Visual Maps

New research has facilitated the development of an artificial intelligence model that can detect illnesses by examining medical images. This model can accurately pick out tumors and provide reasons for every diagnosis given via visual maps. This tool’s development marks an important advancement in the healthcare technology field, because it will simplify the process of detecting illnesses as well as the diagnosis process. The study was led by Beckman Institute graduate research assistant Sourya Sengupta, who highlighted that the study’s focus was on detecting cancer in its early stages. The visual maps produced by the model, dubbed equivalency maps, are…

WednesdayMar 13, 2024 10:15 am

Medicare Physician Pay Reduction Renews Calls for System Overhaul

Congress has once again failed to halt a physician pay cut that will affect access to high-quality care by patients on Medicare. In a recently struck deal, the House voted to decrease this year’s proposed pay-cut for physicians by half, with the Senate expected to vote on the same measure. The need to reform physician payment is dire, with the American Medical Association (AMA) showing that the system in use at the moment is unsustainable. This comes after Medicare physicians received a 2% reduction in their pay in 2023. In a statement, Jesse M. Ehrenfeld, president of the American Medical…